Theravance Biopharma, Inc. · NASDAQ:TBPH

Newtyn Management, LLC reported a 9.70% stake in Theravance Biopharma, Inc. (Schedule 13G/A)

Event Dec 31, 2024 · Filed Feb 14, 2025

Newtyn Management, LLC reported a 9.70% stake in Theravance Biopharma, Inc., 4,757,403 shares, as a passive investor on Dec 31, 2024. Filed Feb 14, 2025 (Schedule 13G/A).

Stake
9.70%
Shares
4,757,403
Intent
Passive
What changed
Stake changed
Filed together
2 holders

The filing in full

HolderStakeShares
Newtyn Management, LLC9.70%4,757,403
Newtyn TE Partners, LP5.90%2,902,002

Source

View original at SEC

Related